Announce Date | 01/31/2025 |
EPS Normalized Actual | $1.04 (Beat by $0.03) |
EPS GAAP Actual | $1.04 (Beat by $0.03) |
Revenue Actual | $0.205182B |
Revenue Surprise | Beat by $205.182M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.96744 |
EPS GAAP Estimate | $0.96744 |
Revenue Estimate | $0.203516406B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 6.2 | 29.83 | 5.98464 | 6.56443 | 1 |
Dec 2027 | 4.58 | 40.38 | 4.25126 | 4.87497 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.05 | 1.05 | 0.205182B | 11.08% | 205.18M |
FQ3 2024 (Sep 2024) | 1.09 | 1.09 | 0.208438B | 10.67% | 208.44M |
FQ2 2024 (Jun 2024) | 1.13 | 1.13 | 0.216658B | 18.83% | 216.66M |
FQ1 2024 (Mar 2024) | 0.99 | 0.99 | 0.19628B | 18.94% | 196.28M |
FQ4 2023 (Dec 2023) | 0.84 | 0.84 | 0.18244B | 19.25% | 182.44M |
FQ3 2023 (Sep 2023) | 0.89 | 0.89 | 0.186193B | 20.51% | 186.19M |
FQ2 2023 (Jun 2023) | 0.77 | 0.77 | 0.175858B | 21.62% | 175.86M |
FQ1 2023 (Mar 2023) | 0.66 | 0.66 | 0.159101B | 100% | 159.1M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.96744
Consensus Revenue Estimates
0.203516406B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.53893 | -- | 1.48357 | 1.57494 | 1 |
FQ2 2027 (Jun 2027) | 1.51947 | -- | 1.46481 | 1.55503 | 1 |
FQ1 2027 (Mar 2027) | 1.37125 | -- | 1.34586 | 1.39128 | 1 |
FQ4 2026 (Oct 2026) | 1.2467 | -- | 1.21397 | 1.31798 | 0 |
FQ3 2026 (Jul 2026) | 1.25021 | -- | 1.21738 | 1.32169 | 0 |
FQ2 2026 (Jun 2026) | 1.13864 | -- | 1.06307 | 1.18169 | 1 |
FQ1 2026 (Mar 2026) | 1.07557 | -- | 1.00419 | 1.11623 | 1 |
FQ4 2025 (Oct 2025) | 1.32292 | 20.63 | 1.28819 | 1.39856 | 1 |
FQ3 2025 (Jul 2025) | 1.2584 | 13.38 | 1.22536 | 1.33035 | 1 |
FQ2 2025 (Jun 2025) | 0.96744 | -16.8 | 0.90323 | 1.00401 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.29B | -- | 0.28B | 0.29B | 2 |
FQ2 2027 (Jun 2027) | 0.28B | -- | 0.27B | 0.28B | 2 |
FQ1 2027 (Mar 2027) | 0.27B | -- | 0.26B | 0.27B | 2 |
FQ4 2026 (Oct 2026) | 0.24B | -- | 0.23B | 0.25B | 1 |
FQ3 2026 (Jul 2026) | 0.23B | -- | 0.23B | 0.24B | 1 |
FQ2 2026 (Jun 2026) | 0.22B | -- | 0.21B | 0.23B | 2 |
FQ1 2026 (Mar 2026) | 0.22B | -- | 0.21B | 0.22B | 2 |
FQ4 2025 (Oct 2025) | 0.24B | 12.98 | 0.23B | 0.25B | 0 |
FQ3 2025 (Jul 2025) | 0.23B | 8.07 | 0.22B | 0.24B | 0 |
FQ2 2025 (Jun 2025) | 0.2B | -6.46 | 0.19B | 0.21B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.05 | 1.05 | 100% | |
FQ3 2024 (Sep 2024) | 1.09 | 1.09 | 100% | |
FQ2 2024 (Jun 2024) | 1.13 | 1.13 | 100% | |
FQ1 2024 (Mar 2024) | 0.99 | 0.99 | 100% | |
FQ4 2023 (Dec 2023) | 0.84 | 0.84 | 100% | |
FQ3 2023 (Sep 2023) | 0.89 | 0.89 | 100% | |
FQ2 2023 (Jun 2023) | 0.77 | 0.77 | 100% | |
FQ1 2023 (Mar 2023) | 0.66 | 0.66 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.21B | $205.18M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.21B | $208.44M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.22B | $216.66M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.2B | $196.28M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.18B | $182.44M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.19B | $186.19M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.18B | $175.86M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.16B | $159.1M | 100% |